InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed’s pipeline includes programs in the treatment of Alzheimer’s, ocular and dermatological indications.

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. It operates through two segments: InMed Pharma...

5 天之前 · InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It operates through the InMed Pharma and BayMedica segments. The InMed Pharma segment is organized around...

InMed is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (CBN), in diseases with high unmet medical need.

Get the latest InMed Pharmaceuticals Inc (INM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading...

2017年1月22日 · InMed Pharmaceuticals is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting CB1/CB2 receptors. InMed’s pipeline consists of three separate programs in the treatment of Alzheimer’s disease and ocular and dermatological indications.

2 天之前 · InMed's proprietary IVT formulation, combined with the INM-089 active pharmaceutical ingredient ('API'), has been successfully delivered to the targeted area of the eye in preclinical studies in ...

InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It operates through the InMed Pharma and BayMedica segments. The InMed Pharma segment is …

6 天之前 · InMed Pharmaceuticals focuses on its proprietary platform technology, drug discovery, and commercialization development. Stock analysis for InMed Pharmaceuticals Inc (INM:NASDAQ CM)...

Get the latest InMed Pharmaceuticals Inc. (INM) stock news and headlines to help you in your trading and investing decisions.